{"id":38835,"date":"2025-07-03T11:41:44","date_gmt":"2025-07-03T09:41:44","guid":{"rendered":"https:\/\/www.abcsg.org\/abcsg-studien\/studies-open-for-enrollment\/abcsg-61-uebersicht\/"},"modified":"2025-07-05T05:14:06","modified_gmt":"2025-07-05T03:14:06","slug":"abcsg-61-uebersicht","status":"publish","type":"page","link":"https:\/\/www.abcsg.org\/en\/abcsg-studien\/studies-open-for-enrollment\/abcsg-61\/abcsg-61-uebersicht\/","title":{"rendered":"ABCSG 61 \/ TEODOR Overview"},"content":{"rendered":"<p>Neoadjuvant <strong>T<\/strong>r<strong>E<\/strong>atment <strong>O<\/strong>ptimization driven by ct<strong>D<\/strong>NA and end<strong>O<\/strong>crine <strong>R<\/strong>esponsiveness<\/p>\n<p>A prospective, randomized, controlled, open-label multicenter phase II study investigating neoadjuvant endocrine therapy versus chemotherapy in HR-positive, HER2-negative, ctDNA-negative and endocrine responsive early and locally advanced breast cancer<\/p>\n<table class=\"studienmeta-public\">\n<tbody>\n<tr>\n<td>Study Start:<\/td>\n<td>Q3\/2025<\/td>\n<\/tr>\n<tr>\n<td>Coordinating Investigators:<\/td>\n<td>Michael Gnant, Vienna<br \/>\nDaniel Egle, Innsbruck<\/td>\n<\/tr>\n<tr>\n<td>Participants:<\/td>\n<td>256 (national)<\/td>\n<\/tr>\n<tr>\n<td>Study Design:<br \/>\n<em>(Click to enlarge)<\/em><\/td>\n<td><a  href=\"https:\/\/www.abcsg.org\/wp\/wp-content\/uploads\/2025\/07\/61_Study-Design_20250618-scaled.jpg\" data-rel=\"lightbox-gallery-0\" data-rl_title=\"\" data-rl_caption=\"\" title=\"\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-38843\" src=\"https:\/\/www.abcsg.org\/wp\/wp-content\/uploads\/2025\/07\/61_Study-Design_20250618-280x148.jpg\" alt=\"ABCSG 61 Study Design\" width=\"280\" height=\"148\" srcset=\"https:\/\/www.abcsg.org\/wp\/wp-content\/uploads\/2025\/07\/61_Study-Design_20250618-280x148.jpg 280w, https:\/\/www.abcsg.org\/wp\/wp-content\/uploads\/2025\/07\/61_Study-Design_20250618-1500x795.jpg 1500w, https:\/\/www.abcsg.org\/wp\/wp-content\/uploads\/2025\/07\/61_Study-Design_20250618-768x407.jpg 768w, https:\/\/www.abcsg.org\/wp\/wp-content\/uploads\/2025\/07\/61_Study-Design_20250618-1536x814.jpg 1536w, https:\/\/www.abcsg.org\/wp\/wp-content\/uploads\/2025\/07\/61_Study-Design_20250618-2048x1086.jpg 2048w\" sizes=\"auto, (max-width: 280px) 100vw, 280px\" \/><\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Neoadjuvant TrEatment Optimization driven by ctDNA and endOcrine Responsiveness A prospective, randomized, controlled, open-label multicenter phase II study investigating neoadjuvant endocrine therapy versus chemotherapy in HR-positive, HER2-negative, ctDNA-negative and endocrine responsive early and locally advanced breast cancer Study Start: Q3\/2025 Coordinating Investigators: Michael Gnant, Vienna Daniel Egle, Innsbruck Participants: 256 (national) Study Design: (Click to [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":38833,"menu_order":4,"comment_status":"closed","ping_status":"closed","template":"page-einzel-studie.php","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"class_list":["post-38835","page","type-page","status-publish","hentry"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-11-18 20:59:29","action":"delete","newStatus":"draft","terms":[],"taxonomy":"translation_priority","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages\/38835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/comments?post=38835"}],"version-history":[{"count":5,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages\/38835\/revisions"}],"predecessor-version":[{"id":38870,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages\/38835\/revisions\/38870"}],"up":[{"embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages\/38833"}],"wp:attachment":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/media?parent=38835"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/tags?post=38835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}